Introducing the new AltIndexLearn more
$33,000
Est. net congressional buying / selling (2 years). Updated Jun 19, 2026

Are Members of Congress Buying or Selling Check Point Software Technologies?

1 member of the U.S. Congress has traded Check Point Software Technologies (CHKP) stock in the past 90 days, all sales. Congressional trades are reported under the STOCK Act and are typically disclosed within 45 days of the transaction.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the CHKP AI Score. For corporate insider activity, see CHKP insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading Check Point Software Technologies?

Member of CongressActivityTradesLast Trade
Thomas H. Kean Bought $41,000 3 Jun 1, 2026

CHKP Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
Thomas H. Kean Jun 1, 2026 Sell $1K – $15K
Thomas H. Kean Aug 4, 2025 Buy $1K – $15K
Thomas H. Kean Jul 29, 2025 Buy $15K – $50K

Frequently Asked Questions: Check Point Software Technologies Congress Trading

In the past 90 days, members of Congress have made 0 purchases and 1 sale of CHKP stock. The net selling may reflect profit-taking or reduced exposure. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

Thomas H. Kean sold Check Point Software Technologies (CHKP) stock most recently, on June 1, 2026.

The estimated net value of congressional trades in Check Point Software Technologies over the past 2 years is positive, at $33,000, meaning members of Congress have on balance bought more than they have sold.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.